InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Session R.A. II. Director active across 1 companies, notably Taysha Gene Therapies, Inc.. In total, 2 filings have been published. Total volume traded: €356k. The latest transaction was disclosed on 23 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€177,99216,510 shares@ €10.7809100.0% of flow
Common Stock
SEC:0001209191-21-068510·
Ideal exit: 20 Aug 2022 (T+270)
€177,99216,510 shares@ €10.78090.010% mcap50.0% of flow
Common Stock
SEC:0001209191-21-068510:0·
Ideal exit: 20 Aug 2022 (T+270)
2 of 2 declarations
